The findings of the study, looking at the effect of CT screening on smokers at high-risk of developing lung cancer, dispute the belief that a negative screening result offers a ‘licence to smoke’ and reveal that engaging with lung screening can give smokers an opportunity to access smoking cessation support, at a time when they are likely to be receptive to offers of help.
Dr Kate Brain, Reader at Cardiff University’s Division of Population Medicine, said: “Our trial shows that CT lung cancer screening offers a teachable moment for smoking cessation among high-risk groups in the UK….”
The trial, led by researchers at Cardiff University working with the University of Liverpool, King’s College London and Queen Mary University, involved 4,055 participants aged 50-75 years who were randomised either to a group who underwent low-dose CT screening for early detection of lung cancer, or to a control group who did not undergo screening.
Of the smokers who took part in the screening, 10% had successfully quit after two weeks, and 15% had quit at two years – both higher than rates in the control group.
Highest mortality of all cancers
The UK Lung Cancer Screening (UKLS) pilot trial is the first to assess the feasibility, cost-effectiveness and behavioural impact of lung cancer screening, using a single low-dose CT screen on a high-risk population in the UK.
Lung cancer is one of the most common and serious types of cancer and has the highest mortality of all cancers in the UK. Around 44,500 people are diagnosed with the condition every year in the UK.
The UKLS pilot trial was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme.
The full scientific publication ‘Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial’ is published in Thorax .